
Ligand Pharmaceuticals Incorporated (LGND)
US$ 113.51-5.69%
Price Chart
Key Statistics
Market Cap
$ 2.19B
P/E Ratio
0.00
Revenue (TTM)
$ 181.49M
Volume
104.55K
52W High
$ 129.90
52W Low
$ 81.74
Dividend Yield
0.00%
Beta
0.71
Technicals
50-Day MA
107.7416
200-Day MA
110.3608
52 Week High
129.9
52 Week Low
81.74
About LGND
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFiv.
Employees
68
Headquarters
Jupiter, FL
CEO
Mr. Todd C. Davis Ph.D.
Latest News
(LGND) Investment Analysis - news.stocktradersdaily.com
5 days ago • Google News
Insider Sale: CLO & Secretary of $LGND Sells 500 Shares - Nasdaq
1 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg